SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI-based liquid biopsy shows promise for detecting brain cancer

2.

Novel probes to label macrophages associated with cancer progression using a selective dye

3.

A Lot Can Be Said About You by Including Yourself in Photos.

4.

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

5.

Telehealth in the pandemic era resulted in fewer therapy interruptions.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot